Labetalol Hydrochloride 36000-0322-02

Package NDC

36000-0322-02

Manufacturer: Baxter Healthcare Corporation
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: January 26, 2021
Listing Expires: December 31, 2026
Application: ANDA076051

Need to source Labetalol Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Labetalol Hydrochloride	5 mg/mL

Drug Class

Adrenergic beta-Antagonists [MoA]beta-Adrenergic Blocker [EPC]

Selected Package

36000-0322-02Selected

1 VIAL in 1 CARTON (36000-322-02) / 20 mL in 1 VIAL (36000-322-01)